Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial
- Jackson, T. (Speaker)
Activity: Talk or presentation › Oral presentation
Activity: Talk or presentation › Oral presentation